Infectious Disease Research Institute
The Infectious Disease Research Institute (IDRI) was a non-profit organization based in Seattle, in the United States, and which conducts global health research on infectious diseases. Its new name is Access to Advanced Health Institute (AAHI).
History
[edit]IDRI was founded in 1993, by Steve Reed, PhD. [1]
Malaria vaccine
[edit]IDRI is collaborating with the United States Agency for International Development to develop a malaria vaccine with the Walter Reed Army Institute of Research using Walter Reed's CelTOS malaria antigen in conjunction with IDRI's GLA-SE adjuvant.[2]
Visceral leishmaniasis vaccine
[edit]In February 2012, IDRI launched the world's first clinical trial of the visceral leishmaniasis vaccine. The vaccine is a recombinant form of two fused Leishmania parasite proteins with an adjuvant. Two phase 1 clinical trials with healthy volunteers are to be conducted. The first one takes place in Washington and is followed by a trial in India. The trials are funded by the Bill & Melinda Gates Foundation.[3]
References
[edit]- ^ "Home". idri.org. Archived from the original on 2009-03-26. Retrieved 2011-09-12.
- ^ Erica Teichert (18 August 2011). "USAID, IDRI form malaria vax collaboration". fiercevaccines.com. Archived from the original on November 9, 2011. Retrieved 12 September 2011.
{{cite web}}: CS1 maint: unfit URL (link) - ^ Elvidge, Suzanne (February 23, 2012). "World's first kala azar vaccine enters the clinic". FierceVaccines.com. Archived from the original on February 22, 2014. Retrieved March 1, 2012.
{{cite web}}: CS1 maint: unfit URL (link)
